Nutra Pharma Corp (NPHC): NPHC The CEO said that a company with a...

Reply Private New

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	5387
Posts	51347
Boards Moderated	10
Alias Born	09/19/2006

HDOGTX

Re: JusDePomme post# 19550

Thursday, 07/27/2017 1:20:17 PM

Thursday, July 27, 2017 1:20:17 PM

NPHC The CEO said that a company with a Phase 2 drug should have a $100 million dollar market value according to studies. He said based on their pipeline they should have a $30 million market value right now. This according to his spring interview.

https://stockguru.com/nutra-pharma-ceo-rik-deitsch-interview/

This stock only has a market value of $2.4 million dollars right now based on my estimation of around 800 million shares outstanding and a .003 share price. NPHC is ridiculously undervalued at this level. The CEO said it should have a $30 million market value right now. That would put it around .04. Once phase 2 starts it should have a $100 million market value. That would put the share price at .13 per share based on 800 millions shares outstanding

This info is not to be construed as a solicitation to buy/sell securities. Hdogtx reserves the right to either BUY/SELL shares in a company's stock he mentions.